|
|
myosin filament organization
|
GO:0031033 |
3 |
0.846
|
|
|
|
skeletal myofibril assembly
|
GO:0014866 |
4 |
0.740
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.657
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.608
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.513
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.452
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.446
|
Human Zebrafish Rat |
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.416
|
|
|
|
skeletal muscle thin filament assembly
|
GO:0030240 |
2 |
0.414
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.402
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.391
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.359
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.353
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.352
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.350
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.342
|
|
|
|
cardiac myofibril assembly
|
GO:0055003 |
12 |
0.336
|
|
|
|
muscle filament sliding
|
GO:0030049 |
1 |
0.275
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.267
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.256
|
Human Zebrafish Rat |
|
|
blood circulation
|
GO:0008015 |
195 |
0.249
|
Human Zebrafish Rat |
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.249
|
Human |
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.206
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.194
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.183
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.177
|
Human |
|
|
heart contraction
|
GO:0060047 |
93 |
0.175
|
Human Zebrafish Rat |
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.168
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.159
|
Human |
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.159
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.158
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.155
|
Human Zebrafish Rat |
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.153
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.134
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.134
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.126
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.124
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.121
|
Human |
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.111
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.110
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.105
|
Human Zebrafish Rat |
|
|
actin myosin filament sliding
|
GO:0033275 |
1 |
0.104
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.099
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.099
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.098
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.096
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.095
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.093
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.093
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.091
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.090
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.088
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.086
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.086
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.085
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.083
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.082
|
|
|
|
skeletal muscle adaptation
|
GO:0043501 |
16 |
0.081
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.079
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.078
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.077
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.077
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.077
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.077
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.076
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.075
|
Human |
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.074
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.074
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.074
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.073
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.073
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.072
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.072
|
Rat |
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.071
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.069
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.068
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.068
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.067
|
|
|
|
response to muscle stretch
|
GO:0035994 |
1 |
0.067
|
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.065
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.064
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.063
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.063
|
|
|
|
skeletal muscle myosin thick filament assembly
|
GO:0030241 |
1 |
0.062
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.061
|
|
|
|
regulation of skeletal muscle adaptation
|
GO:0014733 |
12 |
0.059
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.059
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.059
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.059
|
|
|
|
tubulin complex assembly
|
GO:0007021 |
2 |
0.058
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.058
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.058
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.058
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.056
|
Human |
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.056
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.056
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.055
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.055
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.054
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.054
|
|
|
|
retinoic acid metabolic process
|
GO:0042573 |
12 |
0.053
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.053
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.053
|
|
|
|
tubulin complex biogenesis
|
GO:0072668 |
2 |
0.053
|
|
|
|
regulation of atp catabolic process
|
GO:1903289 |
9 |
0.051
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.051
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.051
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.050
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.050
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.049
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.047
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.047
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.047
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.046
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.046
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.045
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.045
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.044
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.044
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.044
|
|
|
|
regulation of atp metabolic process
|
GO:1903578 |
17 |
0.043
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.043
|
Human Zebrafish |
|
|
long chain fatty acid import
|
GO:0044539 |
2 |
0.042
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.042
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.042
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.042
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.042
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.041
|
|
|
|
transition between fast and slow fiber
|
GO:0014883 |
9 |
0.041
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.041
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.040
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.040
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.040
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.039
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.039
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.039
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.039
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.039
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.038
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.038
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.038
|
|
|
|
negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway
|
GO:1902176 |
4 |
0.038
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.038
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.038
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.037
|
Human |
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.037
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.036
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.036
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.035
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.035
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.035
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.035
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.034
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.034
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.034
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.034
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.034
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.033
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.033
|
|
|
|
regulation of skeletal muscle contraction
|
GO:0014819 |
3 |
0.033
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.033
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.033
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.032
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.032
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.032
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.032
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.031
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.031
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.031
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.030
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.030
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.030
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.030
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.030
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.030
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.030
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.029
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.029
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.029
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.029
|
|
|
|
positive regulation of atpase activity
|
GO:0032781 |
3 |
0.029
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.029
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.029
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.028
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.028
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.028
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.028
|
|
|
|
endoplasmic reticulum to cytosol transport
|
GO:1903513 |
12 |
0.028
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.028
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.028
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.027
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.027
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.027
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.026
|
|
|
|
regulation of sarcomere organization
|
GO:0060297 |
4 |
0.026
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.026
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.026
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.026
|
|
|
|
p38mapk cascade
|
GO:0038066 |
4 |
0.026
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.026
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.026
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.026
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.026
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.025
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.025
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.025
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.025
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.025
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.025
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.025
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.024
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.024
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.024
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.024
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.024
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.024
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.024
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.024
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.023
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.023
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.023
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.023
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.023
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.023
|
|
|
|
response to uv a
|
GO:0070141 |
1 |
0.022
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.022
|
|
|
|
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
GO:0010880 |
10 |
0.022
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.022
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.021
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.021
|
|
|
|
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
GO:0014808 |
12 |
0.021
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.021
|
Human |
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.021
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.021
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.021
|
|
|
|
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion
|
GO:0010881 |
7 |
0.021
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.021
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.021
|
|
|
|
regulation of the force of heart contraction
|
GO:0002026 |
17 |
0.021
|
|
|
|
response to vitamin a
|
GO:0033189 |
1 |
0.021
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.021
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.021
|
|
|
|
sinoatrial node cell development
|
GO:0060931 |
3 |
0.021
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.020
|
|
|
|
regulation of phospholipid biosynthetic process
|
GO:0071071 |
3 |
0.020
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.020
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.020
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.020
|
Human Zebrafish |
|
|
lung development
|
GO:0030324 |
164 |
0.020
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.020
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.020
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.019
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.019
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.019
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.019
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.019
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.019
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.019
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.019
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.019
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.019
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.019
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.019
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.019
|
|
|
|
ovulation
|
GO:0030728 |
15 |
0.019
|
|
|
|
negative regulation of purine nucleotide catabolic process
|
GO:0033122 |
9 |
0.018
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.018
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.018
|
|
|
|
axonal fasciculation
|
GO:0007413 |
15 |
0.018
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.018
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.018
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.018
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.018
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.018
|
|
|
|
notochord cell development
|
GO:0060035 |
1 |
0.018
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.018
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.018
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.018
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.018
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.018
|
|
|
|
negative regulation of nucleoside metabolic process
|
GO:0045978 |
11 |
0.018
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.018
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.018
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.018
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.018
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.018
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.017
|
Human |
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.017
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.017
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.017
|
|
|
|
positive regulation of cardiac muscle contraction
|
GO:0060452 |
2 |
0.017
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.017
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.017
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.017
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.017
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.017
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.017
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.017
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.017
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.017
|
|
|
|
positive regulation of atp catabolic process
|
GO:1903291 |
3 |
0.017
|
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.017
|
|
|
|
notochord development
|
GO:0030903 |
20 |
0.016
|
|
|
|
positive regulation of skeletal muscle cell differentiation
|
GO:2001016 |
4 |
0.016
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.016
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.016
|
|
|
|
regulation of response to oxidative stress
|
GO:1902882 |
19 |
0.016
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.016
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.016
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.016
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.016
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.016
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.016
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.016
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.016
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.016
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.016
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.016
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.016
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.016
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.016
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.016
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.016
|
|
|
|
response to ischemia
|
GO:0002931 |
14 |
0.016
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.016
|
|
|
|
cellular response to arsenic containing substance
|
GO:0071243 |
4 |
0.015
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.015
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.015
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.015
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.015
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.015
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.015
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.015
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.015
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.015
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.015
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.015
|
|
|
|
oligopeptide transmembrane transport
|
GO:0035672 |
4 |
0.015
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.015
|
|
|
|
negative regulation of potassium ion transmembrane transporter activity
|
GO:1901017 |
3 |
0.015
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.014
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.014
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.014
|
|
|
|
glycerophospholipid biosynthetic process
|
GO:0046474 |
32 |
0.014
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.014
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.014
|
|
|
|
relaxation of muscle
|
GO:0090075 |
18 |
0.014
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.014
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.014
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.014
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.014
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.014
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.014
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.014
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.014
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.014
|
|
|
|
muscle cell fate specification
|
GO:0042694 |
1 |
0.014
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway
|
GO:2001243 |
34 |
0.014
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.014
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.014
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.014
|
|
|
|
acetate ester transport
|
GO:1901374 |
2 |
0.014
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.014
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.014
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.014
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.013
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.013
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.013
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.013
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.013
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.013
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.013
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.013
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.013
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.013
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.013
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.013
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.013
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.013
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.013
|
|
|
|
lens morphogenesis in camera type eye
|
GO:0002089 |
24 |
0.013
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.013
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.013
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.013
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.013
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.013
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.013
|
|
|
|
negative regulation of protein complex disassembly
|
GO:0043242 |
22 |
0.013
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.013
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.013
|
|
|
|
regulation of chloride transport
|
GO:2001225 |
2 |
0.013
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.013
|
|
|
|
response to inactivity
|
GO:0014854 |
4 |
0.013
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.013
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.012
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.012
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.012
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.012
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.012
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.012
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.012
|
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.012
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.012
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.012
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.012
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.012
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.012
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.012
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.012
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.012
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.012
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.012
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.012
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.012
|
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.012
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.012
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.012
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.012
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.012
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.012
|
|
|
|
sinoatrial node cell differentiation
|
GO:0060921 |
3 |
0.012
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.012
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.012
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.012
|
Human |
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.012
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.012
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.012
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.012
|
|
|
|
sinoatrial node development
|
GO:0003163 |
4 |
0.012
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.012
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.012
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.012
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.012
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.012
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.012
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.012
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.011
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.011
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.011
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.011
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.011
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
21 |
0.011
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.011
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.011
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.011
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.011
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.011
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.011
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.011
|
|
|
|
glycolipid biosynthetic process
|
GO:0009247 |
13 |
0.011
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.011
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.011
|
|
|
|
regulation of skeletal muscle fiber differentiation
|
GO:1902809 |
3 |
0.011
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.011
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.011
|
|
|
|
regulation of atpase activity
|
GO:0043462 |
9 |
0.011
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.011
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.011
|
|
|
|
nitric oxide metabolic process
|
GO:0046209 |
25 |
0.011
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.011
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.011
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.011
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.011
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.011
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.011
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.011
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.011
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.011
|
|
|
|
muscle cell cellular homeostasis
|
GO:0046716 |
12 |
0.011
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.011
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.011
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.011
|
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
19 |
0.011
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.011
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.010
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.010
|
|
|
|
negative regulation of atpase activity
|
GO:0032780 |
2 |
0.010
|
|